Benzodiazepine receptors modulate circulating plasma vasopressin concentration

Area of Science:

• Neuropharmacology
• Endocrinology

Background:

• Benzodiazepines are known to modulate neuronal activity.
• Arginine-vasopressin (AVP) plays a role in cardiovascular regulation and stress responses.

Purpose of the Study:

• To investigate the role of benzodiazepine receptors in regulating basal and evoked plasma AVP levels.
• To examine the effects of chlordiazepoxide on cardiovascular parameters and AVP release.

Main Methods:

• Administration of chlordiazepoxide or saline pretreatment in spinal animals.
• Picrotoxin challenge to induce changes in plasma AVP and blood pressure.
• Administration of RO 15-1788, a benzodiazepine receptor antagonist, to block chlordiazepoxide effects.

Main Results:

• Chlordiazepoxide pretreatment significantly decreased basal plasma AVP levels.
• Chlordiazepoxide attenuated picrotoxin-induced increases in plasma AVP and blood pressure.
• RO 15-1788 administration blocked the effects of chlordiazepoxide on both basal and evoked AVP levels and blood pressure.

Conclusions:

• Benzodiazepine receptor interactions significantly influence basal plasma AVP concentrations.
• Benzodiazepine receptors modulate the release of AVP in response to stimuli like picrotoxin.
• These findings highlight a link between benzodiazepine receptor activity and the neuroendocrine regulation of AVP.